Chunli Medical (688236.SH) plans to spend 20-40 million yuan to repurchase shares.
Chunli Medical (688236.SH) announced on June 17th that the company intends to repurchase some of the company's issued RMB ordinary shares (A-shares) through centralized bidding trading method, for the implementation of employee shareholding plan and/ or stock-based incentive plan. The total amount of repurchase funds is not less than RMB 20 million (inclusive) and not more than RMB 40 million (inclusive), and the repurchase price does not exceed RMB 28.56 per share (inclusive).
The chairman of Chunli Medical (688236.SH) has proposed that the company spend 20-40 million yuan to repurchase its shares.
Chunli Medical (688236.SH) announced that on June 13, 2024, the company received a letter from the company's chairman...
Chunli Medical (01858) plans to renew Daxin Certified Public Accountants as domestic and foreign financial auditing agency and internal control auditing agency in 2024
Chunli Medical (01858) issued an announcement. In order to maintain the continuity and stability of the audit work, the Board of Directors Audit Committee...
Chunli Medical (01858) nominated Xu Hong as an independent director candidate for the 5th board of directors
Chunli Medical (01858) issued an announcement. The company's board of directors recently received a letter from the company's independent director Yao Lijie...
Zhongtai Securities: Steady performance under the influence of policies and fundamentals, grasping investment opportunities driven by medical device innovation+ inflection points
The medical device industry continues to grow rapidly. It is optimistic about importation substitution and global development driven by innovation. Volume procurement policies will continue to be implemented, medical anti-corruption is expected to ease, and sector valuations are expected to gradually recover.
Chunli Medical's net profit of 55,1996 million yuan in the first quarter decreased by 1.18% year-on-year
Chunli Medical (01858) released its report for the first quarter of 2024, with operating income of 222 million yuan (RMB, same below), down 9.95% year on year; net profit attributable to shareholders of listed companies was 55,1996 million yuan, down 1.18% year on year; basic earnings per share were 0.14 yuan.
春立醫療:2024年第一季度報告
春立醫療:2023 年報
Chunli Medical (688236.SH) announced first-quarter results, net profit of 55.2 million yuan, a year-on-year decrease of 1.18%
Chunli Medical (688236.SH) disclosed its report for the first quarter of 2024. The company achieved revenue of 2.2 during the reporting period...
Chunli Medical (01858.HK) plans to hold a board meeting on April 29 to approve the first quarter results
Gelonghui, April 17, 丨 Chunli Healthcare (01858.HK) issued an announcement. The board of directors will hold a board meeting on April 29, 2024 (Monday) to approve (among others) the announcement of the first quarter results of the company and its subsidiaries for the three months ended March 31, 2024 and consider paying an interim dividend (if any).
From the pain of collection to the decline in net profit distribution, going overseas or becoming the only way out for orthopedic consumables?
As the fourth batch of high-value consumables collected last year directly targeted artificial lenses and high-value orthopedic sports medicine consumables, almost all high-value consumables in the orthopedic field have already been collected. Even if this collection is “mild” compared to the previous three rounds of overall price cuts, it will inevitably have a negative impact on the performance of leading domestic companies in the short term, and there is a certain relationship with the imbalance in the companies' “price for volume” game. Judging from the 2023 financial reports disclosed by many industry companies, the traditional logic of “price for volume” collection has not been fully demonstrated. It is not that the more companies that win the bid, the better their performance growth. On the contrary, the increase in sales brought about by harvesting does not seem to offset the product
Chunli Medical (01858): Wang Jianliang resigns as Deputy General Manager
Zhitong Finance App News, Chunli Medical (01858) issued an announcement. The board of directors recently received a written resignation application from Mr. Wang Jianliang, the company's deputy general manager, to resign as the company's deputy general manager due to personal reasons. After his resignation, Mr. Wang Jianliang will continue to work for the company.
Chunli Medical (01858) will pay a final dividend of 3.62 yuan for every 10 shares on July 31
According to the Zhitong Finance App, Chunli Healthcare (01858) announced that the company will pay a final dividend of RMB 3.62 per 10 shares on July 31, 2024.
Chunli Medical (01858) announced 2023 annual results, net profit of 278 million yuan, a year-on-year decrease of 9.72%, and final interest of 3.62 yuan per 10 shares
Chunli Medical (01858) announced its annual results for the year ended December 31, 2023. The group will take...
CHUNLI MEDICAL: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Guoxin Securities: The pharmaceutical industry is entering an upward inflection point in the medium to long term, and focus on high growth targets in the quarterly report in the short term
The pharmaceutical industry currently has low growth, low profitability, undervaluation, and low transaction attention, and is entering a major layout range at an upward inflection point in the medium to long term.
Chunli Healthcare (01858.HK) plans to hold a board meeting on March 28 to consider and approve the annual results
Gelonghui, March 18, 丨 Chunli Healthcare (01858.HK) announced that the board of directors meeting will be held on March 28, 2024 (Thursday) to approve (among other things) the announcement of the annual results of the Company and its subsidiaries for the financial year ended 31 December 2023 and consider payment of a final dividend (if any).
CHUNLI MEDICAL: NOTICE OF BOARD MEETING
Chunli Medical (01858) subscribed to structured deposit products with a total amount of 160 million yuan
Chunli Medical (01858) issued an announcement. On March 12, 2024, the company established Bank of Beijing (Fangzhuang Branch)...
Changes in Hong Kong stocks | Chunli Healthcare (01858) fell by more than 4% due to orthopedic collection, terminal sales prices fell, and the company did not increase profit last year
Chunli Healthcare (01858) fell by more than 4%. As of press release, it was down 4.37% to HK$9.64, with a turnover of HK$2,522,100.
No Data